JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sendid, B.
Right arrow Articles by Poulain, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sendid, B.
Right arrow Articles by Poulain, D.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2004, p. 164-171, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.164-171.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Increased Sensitivity of Mannanemia Detection Tests by Joint Detection of {alpha}- and ß-Linked Oligomannosides during Experimental and Human Systemic Candidiasis

Boualem Sendid,1,2 Thierry Jouault,1 Richard Coudriau,2 Daniel Camus,2 Frank Odds,3,{dagger} Marc Tabouret,4 and Daniel Poulain1,2*

Laboratoire de Mycologie Fondamentale et Appliquée, INSERM 0360,1 Laboratoire de Parasitologie-Mycologie, CH & U, Faculté de Médecine, Pôle Recherche, F-59045 Lille,2 Bio-Rad Laboratories, 59114 Steenvoorde, France,4 Department of Bacteriology and Mycology, Janssen Research Foundation, B-2340 Beerse, Belgium3

Received 13 May 2003/ Returned for modification 16 July 2003/ Accepted 22 October 2003

An enzyme immunoassay (EIA)—the commercially available Platelia Candida antigen test—developed for the diagnosis of systemic candidiasis is based on the detection of {alpha}-linked oligomannose residues ({alpha}-Man) released from Candida cells into the serum. This test has good specificity but has to be repeated frequently because of the rapid clearance of detectable mannanemia. We have developed a second EIA based on detection of beta-linked oligomannoses (ß-Man), since ß-Man are linked to different Candida molecules and interact differently with the host immune system and endogenous lectins and should therefore present different kinetics of serum clearance. In a guinea pig model of Candida albicans systemic infection, the relative amounts of detectable {alpha}- and ß-Man differed considerably according to the virulence of the strain, the infecting dose, and the time after challenge that serum samples were drawn. Detection of {alpha}-Man was more sensitive per serum sample than that of ß-Man, and the sensitivity for the combination reached 90%. The same tests were applied to 90 sera from 26 patients selected retrospectively for having been infected with the most-pathogenic Candida species: C. albicans (19), C. tropicalis (4), and C. glabrata (3). A total of 22 patients had positive antigenemia, 4 had {alpha}-mannanemia, 4 had ß-mannanemia, and 14 showed the presence of both. For the patients showing the presence of both forms of mannanemia, the use of both tests enhanced the duration of the detection of mannanemia. Mannanemia was correlated with early clinical symptoms and isolation of Candida in culture, which occurred in 55% of the patients at an average of 4.7 days after the first positive mannanemia test result. A combination of the two tests had a cumulated specificity of 95%, and positive and negative predictive values were 79 and 97%, respectively. These findings provide evidence for different kinetics of ß- and {alpha}-Man circulation during experimental and human candidiasis and suggest the joint detection of both types of epitopes as a rational approach contributing to increases in the sensitivity and earliness of diagnosis.


* Corresponding author. Mailing address: Laboratoire de Mycologie Fondamentale et Appliquée, CH & U, Faculté de Médecine Pôle Recherche, 1, Place de Verdun, 59045 Lille Cedex, Lille F-59045, France. Phone: 33 03 20 44 55 77. Fax: 33 03 20 44 42 64. E-mail: dan_poulain{at}compuserve.com.

{dagger} Present address: Department of Molecular & Cell Biology, Institute of Medical Sciences, Aberdeen AB25 2ZD, United Kingdom.


Journal of Clinical Microbiology, January 2004, p. 164-171, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.164-171.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.